Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients.
Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients.
复制标题
在一项针对高风险供体血清阳性、受者血清阴性肝移植受者中预防 CMV 疾病的先发性治疗和抗病毒预防的随机试验中，巨细胞病毒 (CMV) DNA 血症与长期死亡率的关联。
DOI：
10.1093/cid/ciad643
复制
发表时间：
2024
期刊：
影响因子：
--
通讯作者：
Limaye,AjitP
中科院分区：
文献类型：
--
作者：
Kumar,Lakshin;Dasgupta,Sayan;Murray-Krezan,Cristina;Singh,Nina;Rakita,RobertM;Fisher,CynthiaE;Limaye,AjitP
在一项针对D+R-肝移植受者CMV先发制人治疗与抗病毒预防的随机试验中，CMV DNAemia与长期死亡率相关性的事后分析显示，干预后CMV DNAemia与研究组调整后的死亡率增加相关。
In a post-hoc analysis of the association of CMV DNAemia with long-term mortality in a randomized trial of CMV preemptive therapy vs. antiviral prophylaxis in D+R- liver transplant recipients, post-intervention CMV DNAemia was associated with increased mortality after adjusting for study arm.